Anabolic effects of a non-myotoxic dose of the β2- adrenergic receptor agonist clenbuterol on rat plantaris muscle

Muscle and Nerve

Volumn 35, Issue 2, 2007, Pages 217-223

  Burniston, Jatin G ^a   McLean, Lynn ^b   Beynon, Robert J ^b   Goldspink, David F ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

2D electrophoresis; Clenbuterol; Histochemistry; Mass spectrometry; Muscle growth; Muscle wasting

Indexed keywords

ADENYLATE KINASE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ENOLASE; CLENBUTEROL; ENOLASE; HEAT SHOCK PROTEIN 72; PHOSPHOGLYCERATE MUTASE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CELL DEATH; CONTROLLED STUDY; DOSE CALCULATION; FAST MUSCLE; FAST MUSCLE FIBER; HISTOCHEMISTRY; MALE; MUSCLE CELL; MUSCLE GROWTH; MUSCLE HYPERTROPHY; NONHUMAN; OPTICAL DENSITY; OSMOTIC PUMP; PHENOTYPE; PLANTARIS MUSCLE; PRIORITY JOURNAL; PROTEOMICS; QUALITATIVE ANALYSIS; RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; CLENBUTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; MALE; MUSCLE FIBERS; MUSCLE PROTEINS; MUSCLE, SKELETAL; PROTEOMICS; RATS; RATS, WISTAR;

EID: 33846968823     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20684     Document Type: Article

References (45)

1. Argiles J, Almendro V, Busquets S, Lopez-Soriano FJ. The pharmacological treatment of cachexia. Curr Drug Targets 2004;5:265-277.
2. Bakker AJ, Head SI, Wareham AC, Stephenson DG. Effect of clenbuterol on sarcoplasmic reticulum function in single skinned mammalian skeletal muscle fibres. Am J Physiol 1998;274:C1718-C1726.
3. Bozzo C, Stevens L, Toniolo L, Mounier Y, Reggiani C. Increased phosphorylation of myosin light chain associated with slow-to-fast transition in rat soleus. Am J Physiol 2003;285:C575-C583.
4. 2- adrenergic receptor agonist, clenbuterol. Muscle Nerve 2005;32:767-774.
5. 2-adrenergic receptor agonist clenbuterol in rat striated muscles. Muscle Nerve 2006;33:655-663.
6. Burniston JG, Ng Y, Clark WA, Colyer J, Tan L-B, Goldspink DF. Myotoxic effects of clenbuterol in the rat heart and soleus muscle. J Appl Physiol 2002;93:1824-1832.
7. 2-adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle. J Appl Physiol 2005;98:1379-1386.
8. Busquets S, Figueras MT, Fuster G, Almendro V, Moore-Carrasco R, Ametiller E, et al. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Res 2004;64:6725-6731.
9. Choo JJ, Horan MA, Little RA, Rothwell NJ. Anabolic effects of clenbuterol in skeletal muscle are mediated by beta2-adrenoceptor activation. Am J Physiol 1992;263;E50-E56.
10. Cornelio F, Di Donato S. Myopathies due to enzyme deficiencies. J Neurol 1985;232:329-340.
11. Desplanches D, Ecochard L, Sempore B, Mayet-Sornay MH, Favier R. Skeletal muscle HSP72 response to mechanical unloading: influence of endurance training. Acta Physiol Scand 2004;180:387-394.
12. Dodd SL, Powers SK, Vrabas IS, Criswell D, Stetson S, Hussain R. Effects of clenbuterol on the contractile and biochemical properties of skeletal muscle. Med Sci Sport Exerc 1996;28:669-676.
13. Doherty MK, McLean L, Hayter JR, Pratt JM, Robertson DH, El-Shafei A, et al. The proteome of chicken skeletal muscle: changes in soluble protein expression during growth in a layer strain. Proteomics 2004;4:2082-2093.
14. Duchen MR. Mitochondria and calcium: from cell signalling to cell death. J Physiol (Lond) 2000;529:57-68.
15. Duncan ND, Williams DA, Lynch GS. Deleterious effects of chronic clenbuterol treatment on endurance and sprint exercise performance in rats. Clin Sci 2000;98:339-347.
16. Guth L, Samaha FJ. Procedure for the histochemical demonstration of actomyosin ATPase. Exp Neurol 1970;28:365-367.
17. Hesketh JE, Campbell GP, Lobley GE, Maltin CA, Acamovic F, Palmer RM. Stimulation of actin and myosin synthesis in rat gastrocnemius muscle by clenbuterol; evidence for translational control. Comp Biochem Physiol 1992;102C:23-27.
18. Hinkle RT, Hodge KMB, Cody DB, Sheldon RJ, Kobilka BK, Isfort R. Skeletal muscle hypertrophy and anti-hypertrophic effects of clenbuterol are mediated by the beta2-adrenergic receptor. Muscle Nerve 2002;25:729-734.
19. Hittel DS, Hathout Y, Hoffman EP, Houmard JA. Proteome analysis of skeletal muscle from obese and morbidly obese women. Diabetes 2005;54:1283-1288.
20. Ingalls CP, Barnes WS, Smith SB. Interaction between clenbuterol and run training: effects on exercise performance and MLC isoform content. J Appl Physiol 1996;80:795-801.
21. Janssen E, Dzeja PP, Oerlemans F, Simonetti AW, Heerschap A, de Haan A, et al. Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement. EMBO J 2000;19:6371-6381.
22. Jensen J, Brors O, Dahl HA. Different beta-adrenergic receptor density in different rat skeletal muscle fibre types. Pharmacol Toxicol 1995;76:380-385.
23. Kearns CF, McKeever KH. Clenbuterol diminishes aerobic performance in horses. Med Sci Sports Exerc 2002;34:1976-1985.
24. Kurucz I, Morva A, Vaag A, Eriksson KF, Huang X, Groop L, et al. Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes 2002;51:1102-1109.
25. Lynch GS, Hayes A, Campbell SP, Williams DA. Effects of beta2-agonist administration and exercise on contractile activation of skeletal muscle fibres. J Appl Physiol 1996;81:1610-1618.
26. Maltin CA, Delday MI, Hay SM, Baillie AG. Denervation increases clenbuterol sensitivity in muscle from young rats. Muscle Nerve 1992;15:188-192.
27. Maltin CA, Hay SM, Delday MI, Lobley GE, Reeds JP. The action of the beta-agonist clenbuterol on protein metabolism in innervated and denervated phasic muscles. Biochem J 1989;261:965-971.
28. Merkulova T, Dehaupas M, Nevers MC, Creminon C, Alameddine H, Keller A. Differential modulation of alpha, beta and gamma enolase isoforms in regenerating mouse skeletal muscle. Eur J Biochem 2000;267:3735-3743.
29. +2-dependent proteolysis in rat skeletal muscle through beta2-adrenoceptors and cAMP. Am J Physiol 2001;281:E449-E454.
30. Navegantes C, Resano NM, Baviera AM, Migliorini RH, Kettelhut IC. Effect of sympathetic denervation on the rate of protein synthesis in rat skeletal muscle. Am J Physiol Endocrinol Metab 2004;286:E642-E647.
31. Ogata T, Oishi Y, Roy RR, Ohmori H. Endogenous expression and developmental changes of HSP72 in rat skeletal muscles. J Appl Physiol 2003;95:1279-1286.
32. Oishi Y, Imoto K, Ogata T, Taniguchi K, Matsumoto H, Fukuoka Y, et al. Calcineurin and heat-shock proteins modulation in clenbuterol-induced hypertrophied rat skeletal muscles. Pflugers Arch 2004;448:114-122.
33. Oishi Y, Ogata T, Ohira Y, Taniguchi K, Roy RR. Calcineurin and heat shock protein 72 in functionally overloaded rat plantaris muscle. Biochem Biophys Res Commun 2005;330:706-713.
34. Pan SJ, Hancock J, Ding Z, Fogt D, Lee M, Ivy JL. Effects of clenbuterol on insulin resistance in conscious obese Zucker rats. Am J Physiol 2001;280:E554-E561.
35. Pellegrino MA, D'Antona G, Bortolotto S, Boschi F, Pastoris O, Bottinelli R, et al. Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice. Exp Physiol 2004;89:89-100.
36. Piec I, Listrat A, Alliot J, Chambon C, Taylor RG, Bechet D. Differential proteome analysis of aging in rat skeletal muscle. FASEB J 2005;19:1143-1145.
37. Popanda O, Fox G, Thielmann HW. Modulation of DNA polymerases alpha, delta and epsilon by lactate dehydrogenase and 3-phosphoglycerate kinase. Biochim Biophys Acta 1998;1397:102-117.
38. Rajab P, Fox J, Riaz S, Tomlinson D, Ball D, Greenhaff PL. Skeletal muscle myosin heavy chain isoforms and energy metabolism after clenbuterol treatment in the rat. Am J Physiol 2000;279:R1076-R1081.
39. Ryall JG, Plant DR, Gregorevic P, Sillence MN, Lynch GS. Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats. J Physiol (Lond) 2004;555:175-188.
40. Stevens L, Ricart-Firinga C, Gohlsch B, Bastide B, Mounier Y, Pette D. Effects of unweighting and clenbuterol on myosin light and heavy chains in fast and slow muscle of rat. Am J Physiol 2000;279:C1558-15663.
41. Tang H, Cheung WM, Ip FC, Ip NY. Identification and characterization of differentially expressed genes in denervated muscle. Mol Cell Neurosci 2000;16:127-140.
42. Torgan CE, Etgen GJ, Kang HY, Ivy JL. Fibre type-specific effects of clenbuterol and exercise training on insulin-resistant muscle. J Appl Physiol 1995;79:163-167.
43. Yimlamai T, Dodd SL, Borst SE, Park S. Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway. J Appl Physiol 2005;91:71-80.
44. Yoshioka M, Tanaka H, Shono N, Snyder EE, Shindo M, St-Amand J. Serial analysis of gene expression in the skeletal muscle of endurance athletes compared to sedentary men. FASEB J 2003;17:1812-1819.
45. Zeman RJ, Ludemann R, Easton TG, Etlinger JD. Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta 2-receptor agonist. Am J Physiol 1988;254:E726-E732.